MiniMed Group Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023
Cash & Equivalents	298	11	54	58
Cash & Short-Term Investments	298	11	54	58
Cash Growth	2609.09%	-79.63%	-6.90%	-
Accounts Receivable	200	570	507	430
Other Receivables	455	-	-	-
Total Trade Receivables	655	570	507	430
Inventory	341	311	292	298
Other Current Assets	54	48	43	58
Total Current Assets	1,348	939	895	844
Net Property, Plant & Equipment	711	706	636	589
Other Intangible Assets	107	132	161	194
Goodwill	2,256	2,255	2,255	2,255
Other Long-Term Assets	208	169	147	138
Total Assets	4,630	4,201	4,094	4,020
Accounts Payable	300	205	190	213
Accrued Expenses	402	504	328	306
Total Current Liabilities	702	710	518	519
Other Long-Term Liabilities	317	162	128	99
Total Long-Term Liabilities	317	162	128	99
Total Liabilities	1,019	871	647	618
Common Stock	3	-	-	-
Additional Paid-in Capital	3,736	-	-	-
Accumulated Other Comprehensive Income	-12	3	-16	-9
Retained Earnings	-116	3,328	3,464	3,411
Shareholders' Equity	3,611	3,330	3,448	3,402
Total Liabilities & Equity	4,630	4,201	4,094	4,020
Net Cash (Debt)	298	11	54	58
Net Cash Growth	2609.09%	-79.63%	-6.90%	-
Net Cash Per Share	1.16	0.04	0.21	-
Book Value	3,611	3,330	3,448	3,402
Book Value Per Share	14.07	13.17	13.64	-
Tangible Book Value	1,248	943	1,032	953
Tangible Book Value Per Share	4.86	3.73	4.08	-

SEC Filings: 10-K · 10-Q